Navigation Links
Intensive Lifestyle Intervention Program for Overweight or Obese Patients with Nonalcoholic Steatohepatitis Reduces Weight and Improves Overall Liver Health
Date:10/27/2008

Research to be presented Sunday, November 2, 2008 at this year's liver

meeting in San Francisco, California, October 31 - November 4

SAN FRANCISCO, Oct. 27 /PRNewswire/ -- Nonalcoholic steatohepatitis (NASH) is strongly associated with obesity, and there is no approved medical therapy for this chronic progressive liver disease. Researchers tested the effects of weight reduction using a state-of-the-art lifestyle intervention program. To do so, 31 overweight or obese patients with NASH were randomized into two groups. Subjects in the first group were put on a lifestyle intervention program consisting of diet, exercise, and behavior modification. Those in the second group received standard nutrition counseling.

According to Kittichai Promrat, MD, principal investigator of the study, "The lifestyle intervention program focuses on changing both eating and exercise habits with a goal of producing a 7-10% weight loss. Participants were seen weekly in small groups (3 to 5 members) conducted by a Master's level nutritionist or health educator for the first 6 months and bi-weekly during the latter 6 months of the program."

After 48 weeks, those on the lifestyle intervention program successfully lost about 9% of their weight, and had significantly greater improvements in liver biopsy findings (hepatic steatosis and overall histologic NASH activity score), and more improved liver enzyme levels compared to those in the control group. Dr. Promrat concludes, "We were extremely encouraged by the results. Weight loss through lifestyle intervention program improves NASH. This approach should be further evaluated in larger trial."

Abstract title:

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis (NASH)

AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. Thi
'/>"/>

SOURCE AASLD
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
2. Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitors
3. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
4. New Company to Develop Nutritional Interventions Against Chronic Inflammatory and Infectious Diseases
5. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
6. Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT
7. NanoInterventions Launches New, Rapid Testing System for Coronary Stents
8. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
9. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
10. WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL
11. Brain Fitness Program Offers Hope for Breast Cancer Survivors Suffering From Chemobrain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire-FirstCall/ -- Sigma-Aldrich Corporation (...MX conference on Tuesday, December 1st at 1:45 PM ...may listen via live audio broadcast over the Inter...a ldrich.com/ . Users can click the "Webcast" i...rich: Sigma-Aldrich is a leading Life Science an...
(Date:11/24/2009)...v. 24 NeurogesX, Inc. (N...d on developing and commercializing novel pain man...Tonno, President and Chief Executive Officer, is s...ay Health Care Conference, to be held December 1-2...ew York. ,, Mr. DiTonno and Stephen Ghiglieri,...
(Date:11/24/2009)...dpoint has been met for patients with advanced-sta...BEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed positive efficacy data from a Phase 2 study wit...08 (formerly AN-152), in patients with advanced or...
(Date:11/24/2009)...ov. 24 Genomic Health, I...ott, Genomic Health,s Executive Chairman, will pre...Conference in New York City on Tuesday, December 1... and subsequently archived webcast of the presenta...mic Health,s website at http://investor.genomiche...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ewswire-FirstCall/ - Nventa,Biopharmaceuticals Cor...ny,has completed enrollment and initiated dosing o...e escalation trial examining the safety of its,lea...lasia, a precursor to,cervical cancer. HspE7 is an...an papillomavirus (HPV)-related diseases. Patients...
...has been growing interest in the question, if the ...soils via manure application is of environmental r...mber issue of the journal CLEAN, Kreuzig and co-wo...benzimidazole antiparasitics, adding valuable data...vior of veterinary medicinal products in manure an...
...can Society of,Hematology (ASH), the world,s large...expects more than 20,000 attendees at the 49th ASH...rgia World Congress Center in,Atlanta. The meeting...for,blood disorders., "The ASH annual meeting is ...rom around the world to hear the most up-to-date d...
Other Biology Technology:Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 2Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 3Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 4Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 5New insights into the fate of anti-parasitics in manure and manured soils 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 3
(Date:11/24/2009)...e crystallised a protein that may help gut bacteri...could be used by probiotic producers to identify s...ople. , "Probiotics need to interact with cells l...they attach to surfaces in the gut they are more l...ctivity," says Dr Nathalie Juge from the Institute...
(Date:11/24/2009)...he American College of Medical Toxicology (ACMT) h...ication of the Journal of Medical Toxicology (JM... March 2010. It was previously published by the U... of Medical Toxicology , an international, peer-re...nce and practice of medical toxicology. The quart...
(Date:11/24/2009)...tes fish food is a matter of debate. A high-profil...most 50 percent of their carbon from trees and lea...rrestrial and aquatic ecosystems. , But new rese...is not likely to be true. Algae provide a much ric...g to research published this week in the Proceedi...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 1Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 1U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 3
...mplicated in human cancers, researchers from White...nology report in the February 22nd online issue of...t can repress activity of a gene by targeting the ... and starts the process of protein production). ...worms. It took seven years for the second one to b...
...betes, lupus and rheumatoid arthritis occur when t...earchers have not known precisely where the molecu.... Now, a team of scientists from the Whitehead Ins...dentified a key set of genes that lie at the core ...ntists develop new methods for manipulating immune...
... or chicken fillet every now and again could add a...hown for the first time that food enriched with na...ore resistant to the processes of ageing. The conc... hope that the same concept can help extend human ...ses of ageing, reports Marina Murphy in Chemistry ...
Other Biology News:MicroRNA helps prevent tumors 2MicroRNA helps prevent tumors 3Cracking open the black box of autoimmune disease 2Meat and two neutrons -- the key to a longer life 2
RosetteSep Anti-Human IgE, 200 ul from StemCell Technologies, Inc.
...t provides a simple and efficient method for purif... PCR mixes. DNA fragments selectively absorbed in ...traction or at room temperature for PCR product wi...NA can be purified with a single prep using YORBIO...
BAS 2500 Image Analysis System from FUJIFILM Life Science
EasySep FITC Selection Kit, Other from StemCell Technologies, Inc.
Biology Products: